A fast, simple method for screening radiation susceptibility genes by RNA interference

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Radiotherapy can cause significant damage to normal tissues.
• Identifying genes related to radiation susceptibility is crucial for predicting patient responses and minimizing side effects.
• Understanding the molecular mechanisms of radiation response is essential for personalized medicine.

Purpose of the Study:

• To develop and validate a high-throughput screening method for identifying radiation susceptibility genes.
• To discover novel genes involved in normal tissue responses to radiation.
• To enable prediction of individual patient susceptibility to radiotherapy.

Main Methods:

• A 96-well screening protocol was established using cell proliferation assays (alamarBlue, BrdU, sulforhodamine B) and RNA interference (shRNA).
• The protocol was evaluated for its efficiency in detecting known radiation susceptibility genes.
• A trial screen was conducted using 28 shRNA vectors to identify new candidate genes.

Main Results:

• All tested proliferation assays successfully identified the known radiation susceptibility gene PRKDC.
• The screen identified another known gene, CDKN1A.
• A novel radiation susceptibility gene, ATP5G3, was discovered using this method.

Conclusions:

• The developed 96-well screening protocol is a simple, rapid, and effective tool for identifying radiation susceptibility genes.
• This method facilitates large-scale screening for novel genes involved in radiation response.
• The findings contribute to a better understanding of normal tissue radiosensitivity and personalized radiotherapy strategies.